-
公开(公告)号:US07989634B2
公开(公告)日:2011-08-02
申请号:US10579042
申请日:2004-11-12
申请人: Koo Lee , Heui-Sul Park , In-Ae Ahn , Hyun-Ju Yoo , Jong-Yup Kim , Deog-Young Choi , Hyeon-Joo Yim , Kyung-Ha Chung , Dong-Sup Shim , Sang-Kyun Lee , Yutaka Kondoh , Ryoji Hirabayashi , Shugo Honda , Hidetaka Kaku , Jun-ichi Shishikura , Hiroyuki Ito , Takeshi Kurama
发明人: Koo Lee , Heui-Sul Park , In-Ae Ahn , Hyun-Ju Yoo , Jong-Yup Kim , Deog-Young Choi , Hyeon-Joo Yim , Kyung-Ha Chung , Dong-Sup Shim , Sang-Kyun Lee , Yutaka Kondoh , Ryoji Hirabayashi , Shugo Honda , Hidetaka Kaku , Jun-ichi Shishikura , Hiroyuki Ito , Takeshi Kurama
IPC分类号: C07D213/46 , C07D211/70 , C07D401/00
CPC分类号: C04B35/632 , C07D205/04 , C07D207/14 , C07D211/58 , C07D401/12 , C07D403/12 , C07D405/12
摘要: The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
摘要翻译: 本发明涉及有效作为黑皮质素受体激动剂的式1化合物及其药学上可接受的盐,水合物,溶剂化物或异构体,以及包含与活性成分相同的黑皮质素受体激动剂组合物。
-
公开(公告)号:US07097967B2
公开(公告)日:2006-08-29
申请号:US10280587
申请日:2002-10-24
申请人: Aeri Kim , Kwan Hyung Cho , Sun Hwa Lee , Suk Kyoon Yoon , Hee Dong Park , Kyung Ha Chung , Ho Jun Kim , Han Joo Maeng , Tae Hun Kim , Bong Chan Kim , Sung Ji Kim
发明人: Aeri Kim , Kwan Hyung Cho , Sun Hwa Lee , Suk Kyoon Yoon , Hee Dong Park , Kyung Ha Chung , Ho Jun Kim , Han Joo Maeng , Tae Hun Kim , Bong Chan Kim , Sung Ji Kim
IPC分类号: C12Q1/00
CPC分类号: C12Q1/37
摘要: The present invention provides a method of predicting a food-drug interaction in vivo, in the case of an orally administered drug interactive with digestive enzymes in the gastrointestinal tract, by measuring the activity of the drug to the digestive enzymes in vitro, which is based on the fact that the ingestion of foods causes the absorption of drug in vivo to decrease due to the above interaction between a drug and digestive enzymes. The present invention further provides methods of minimizing the change of absorption in vivo caused by the ingestion of foods by reducing the action of digestive enzymes, for example, introduction of prodrugs, modification of the chemical structure of drug, design of drug formulation, etc.
摘要翻译: 本发明提供了一种在体外预测食物 - 药物相互作用的方法,在口服给药的药物与胃肠道中的消化酶相互作用的情况下,通过测量药物对体外消化酶的活性,其基于 关于食物的摄取导致药物在体内的吸收由于药物和消化酶之间的上述相互作用而降低。 本发明还提供了通过减少消化酶的作用,例如引入前药,药物化学结构的改变,药物制剂的设计等,最小化摄入食物引起的体内吸收变化的方法。
-
公开(公告)号:US20070129346A1
公开(公告)日:2007-06-07
申请号:US10579042
申请日:2004-11-12
申请人: Koo Lee , Heui-Sul Park , In-Ae Ahn , Hyun-Ju Yoo , Jong-Yup Kim , Deog-Young Choi , Hyeon-Joo Yim , Kyung-Ha Chung , Dong-Sup Shim , Sang-Kyun Lee , Yutaka Kondoh , Ryoji Hirabayashi , Shugo Honda , Hidetaka Kaku , Jun-ichi Shishikura , Hiroyuki Ito , Takeshi Kurama
发明人: Koo Lee , Heui-Sul Park , In-Ae Ahn , Hyun-Ju Yoo , Jong-Yup Kim , Deog-Young Choi , Hyeon-Joo Yim , Kyung-Ha Chung , Dong-Sup Shim , Sang-Kyun Lee , Yutaka Kondoh , Ryoji Hirabayashi , Shugo Honda , Hidetaka Kaku , Jun-ichi Shishikura , Hiroyuki Ito , Takeshi Kurama
IPC分类号: A61K31/397 , A61K31/401 , A61K31/445 , C07D211/06
CPC分类号: C04B35/632 , C07D205/04 , C07D207/14 , C07D211/58 , C07D401/12 , C07D403/12 , C07D405/12
摘要: The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
摘要翻译: 本发明涉及有效作为黑皮质素受体激动剂的式1化合物及其药学上可接受的盐,水合物,溶剂化物或异构体,以及包含与活性成分相同的黑皮质素受体激动剂组合物。
-
-